As of 2026-03-13, the EV/EBITDA ratio of Swedish Orphan Biovitrum AB (publ) (SOBI.ST) is 8.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SOBI.ST's latest enterprise value is 148,342.78 mil SEK. SOBI.ST's TTM EBITDA according to its financial statements is 18,107.00 mil SEK. Dividing these 2 quantities gives us the above SOBI.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 16.9x | 12.2x |
| Forward P/E multiples | 13.8x - 19.3x | 17.1x |
| Fair Price | 140.65 - 828.96 | 386.47 |
| Upside | -63.5% - 114.9% | 0.2% |
| Date | EV/EBITDA |
| 2026-03-12 | 8.06 |
| 2026-03-11 | 8.19 |
| 2026-03-10 | 8.25 |
| 2026-03-09 | 8.00 |
| 2026-03-06 | 8.01 |
| 2026-03-05 | 8.10 |
| 2026-03-04 | 8.20 |
| 2026-03-03 | 8.13 |
| 2026-03-02 | 8.24 |
| 2026-02-27 | 8.38 |
| 2026-02-26 | 8.46 |
| 2026-02-25 | 8.56 |
| 2026-02-24 | 8.58 |
| 2026-02-23 | 8.67 |
| 2026-02-20 | 8.52 |
| 2026-02-19 | 8.50 |
| 2026-02-18 | 8.89 |
| 2026-02-17 | 8.69 |
| 2026-02-16 | 8.59 |
| 2026-02-13 | 8.62 |
| 2026-02-12 | 8.68 |
| 2026-02-11 | 8.63 |
| 2026-02-10 | 8.47 |
| 2026-02-09 | 8.39 |
| 2026-02-06 | 8.39 |
| 2026-02-05 | 8.22 |
| 2026-02-04 | 7.65 |
| 2026-02-03 | 7.62 |
| 2026-02-02 | 7.40 |
| 2026-01-30 | 7.23 |
| 2026-01-29 | 7.21 |
| 2026-01-28 | 7.29 |
| 2026-01-27 | 7.43 |
| 2026-01-26 | 7.34 |
| 2026-01-23 | 7.34 |
| 2026-01-22 | 7.15 |
| 2026-01-21 | 7.07 |
| 2026-01-20 | 7.00 |
| 2026-01-19 | 7.06 |
| 2026-01-16 | 7.12 |
| 2026-01-15 | 7.29 |
| 2026-01-14 | 7.32 |
| 2026-01-13 | 7.20 |
| 2026-01-12 | 7.17 |
| 2026-01-09 | 7.44 |
| 2026-01-08 | 7.41 |
| 2026-01-07 | 7.24 |
| 2026-01-05 | 7.17 |
| 2026-01-02 | 7.10 |
| 2025-12-30 | 7.15 |